Navigation Links
Instrumentation Laboratory Achieves Record Sales in 2010
Date:3/22/2011

BEDFORD, Mass., March 22, 2011 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced total worldwide sales in 2010 of Euro 474.2 million ($644.9 million US). This represents 11.5% growth v. previous year in current, and 10.3% in local currencies.  In the Company's two major business segments, Critical Care and Hemostasis Diagnostics, worldwide growth in current currencies was 13% (11.9% in local currencies) and 9.7% (8.9% in local currencies), respectively.  

(Logo: http://photos.prnewswire.com/prnh/20100803/NE44435LOGO)

"We continued our robust growth trajectory in 2010, despite continued economic pressure in the healthcare industry," said Josep Manent, Chief Executive Officer at IL.  "Our products offer customers tremendous time-and cost-efficiencies, key benefits in these times of reduced hospital budgets and staff."  

Innovative new product offerings drove growth on both the Hemostasis and Critical Care sides of the business.  

In 2010, the Company launched the ACL TOP® 700 and ACL TOP 700 CTS Hemostasis Testing Systems.  These analyzers joined other members of the ACL TOP Family, including the ACL TOP 700 LAS and ACL TOP 500 CTS, to offer hemostasis laboratories "Testing Process Automation" and complete standardization.  Additionally, the new ACL AcuStar™ system, the first automated, random-access chemiluminescent analyzer dedicated to Hemostasis specialty testing, was launched in Europe.  It is exceptionally easy to use and offers maximum efficiency.  

For the past eight years, the comprehensive HemosIL® line of reagents has consistently dominated the market with the most sophisticated assays for the diagnosis management and monitoring of Hemostasis disorders.  IL continued this trend in 2010 with double digit growth in all key areas, most notably, with D-Dimer and specialty assays, such as Thrombophilia Screening and Bleeding Disorders reagents.  The introduction of several key new assays, including HemosIL Liquid Heparin assay for monitoring unfractionated and low-molecular weight heparin, and the European release of the HemosIL HIT-Ab assay for ACL TOP systems, solidified IL's position as the innovation leader in Hemostasis testing solutions.  Further, the HemosIL AcuStar anti-phospholipid syndrome (APS) panel, including HemosIL AcuStar aCL IgG & IgM and HemosIL AcuStar B2GPI IgG & IgM, received 510(K) clearance from the FDA.  These assays, along with the Lupus Anticoagulant tests on the ACL TOP Systems, complete the panel of tests for the diagnosis of APS, according to ISTH guidelines.

On the Critical Care side of the business, sales of the Company's flagship offering , the GEM® Premier™ 4000 analyzer, grew considerably throughout the world due to its ease of use and its Intelligent Quality Management (iQM®) automated quality assurance system.  The new Total Bilirubin assay on the GEM Premier 4000 received 510(K) clearance from the FDA and was launched in the US in 2010, providing rapid, lab-quality results in Neonatal Intensive Care Units.  To better manage a series of GEM Premier 4000 analyzers in a hospital network, IL introduced new GEMweb®Plus 200 Custom Connectivity, offering new features, such as Operator Certification and Advanced Regulatory Management.  Additionally, for a complete critical care testing system, IL introduced GEMdraw Arterial Blood Samplers, featuring GEM EasyDraw and GEM SafetyDraw aspirators and syringes.

"Overall, 2010 was an outstanding year for IL.  We compete in a challenging industry so it is remarkable to see above-market growth, year after year," said Ramon Benet, Senior Vice President, Marketing, Sales & Service at IL.  "Our customers recognize the unique value our products deliver and understand that we are truly passionate about delivering the very best, most innovative products, to ensure optimal patient care.  We never forget that at the end of every single test, is a critically important human life."

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories.  The company's product lines include critical care systems, hemostasis systems and information management systems.  IL's GEM® product offerings, part of the critical care line, include the GEM Premier™ 4000 analyzer with Intelligent Quality Management (iQM®), GEM Premier 3500, GEMweb® Plus Custom Connectivity, and the GEM PCL Plus, a portable coagulation analyzer.  IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the new ACL TOP 700, the new ACL TOP 700 LAS and the ACL TOP 500 CTS.  IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents.  IL is based in Bedford, Massachusetts.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions.  All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.


'/>"/>
SOURCE Instrumentation Laboratory
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
2. Instrumentation Laboratory Installs 2000th ACL TOP(R) System
3. Amerinet Awards Contract to Instrumentation Laboratory for Critical Care Portfolio
4. Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay
5. Patient-Specific Surgical Instrumentation Expedites Total Knee Replacement Procedures
6. Instrumentation Laboratory Achieves Record Sales in 2009
7. Instrumentation Laboratory Receives FDA Clearance for New Automated Total Bilirubin Assay on GEM Premier 4000 Critical Care Analyzer
8. Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe
9. Specialty Surgical Instrumentation Launches New Interactive Web Site
10. Instrumentation Laboratory to Host 2nd Asia Pacific Hemostasis Forum
11. Reportlinker Adds Global Ophthalmic Instrumentation Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Empty Capsules Market is poised ... to reach approximately $2.9 billion by 2025. This industry ... on global as well as regional levels presented in the research scope. ...
(Date:2/24/2017)... HARRISBURG, Pa. , Feb. 24, 2017 ... Secretary of Drug and Alcohol Programs Jennifer Smith ... role in providing training for and using naloxone, a ... Mark McCullough , a recovery specialist and overdose ... naloxone by EMS providers. "A significant part ...
(Date:2/24/2017)... Juan Monteverde , founder and managing ... boutique securities firm headquartered at the Empire State Building ... that a class action lawsuit has been filed in the ... Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or the "Company") on ... 2015 and December 30, 2016, inclusive (the "Class Period").  ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... ... ... The 89th Academy Awards will be celebrated this weekend, which means it’s ... Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the shoddiest ... for American Progress (CAP), for its report, Lessons From State Performance on NAEP: Why ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... ... , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be ... Hot,” which will begin airing on February 24, 2017. The show chronicles the weight ... reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted ...
Breaking Medicine News(10 mins):